Pharmaceutical

Cellusion shares pipeline update for eye disease stem cell therapy

Cellusion shares Phase I/II clinical development plans for its bullous keratopathy stem cell therapy CSL-001.

Jun 29, 2023 - 20:00
Cellusion shares pipeline update for eye disease stem cell therapy
Cellusion shares Phase I/II clinical development plans for its bullous keratopathy stem cell therapy CSL-001.
Read the original article

Tags:

Previous Article

Pfizer’s Ngenla finally secures FDA approval following a rocky road to market

Next Article

The promising role of GLP-1RAs in NASH

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals

STAT+: With Fat Joe concerts and Super Bowl ads, a cadr...

May 25, 2023

Opinion: I saw firsthand in Nigeria that drugs alone can’t win the war against tuberculosis

Opinion: I saw firsthand in Nigeria that drugs alone ca...

Aug 7, 2023

Flamingo gets grant from VLAIO to accelerate RNA-focused oncology portfolio

Flamingo gets grant from VLAIO to accelerate RNA-focuse...

Jun 17, 2023